| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |